Influence of vitreomacular interface score on treatment outcomes of anti-VEGF therapy for neovascular age-related macular degeneration

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2056-9920
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Influence of vitreomacular interface score on treatment outcomes of anti-VEGF therapy for neovascular age-related macular degeneration ; volume:7 ; number:1 ; day:20 ; month:12 ; year:2021 ; pages:1-8 ; date:12.2021
International Journal of Retina and Vitreous ; 7, Heft 1 (20.12.2021), 1-8, 12.2021

Creator
Miyata, Manabu
Ooto, Sotaro
Yamashiro, Kenji
Tamura, Hiroshi
Uji, Akihito
Miyake, Masahiro
Muraoka, Yuki
Takahashi, Ayako
Tsujikawa, Akitaka
Contributor
SpringerLink (Online service)

DOI
10.1186/s40942-021-00342-4
URN
urn:nbn:de:101:1-2022041421082078461953
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:33 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Miyata, Manabu
  • Ooto, Sotaro
  • Yamashiro, Kenji
  • Tamura, Hiroshi
  • Uji, Akihito
  • Miyake, Masahiro
  • Muraoka, Yuki
  • Takahashi, Ayako
  • Tsujikawa, Akitaka
  • SpringerLink (Online service)

Other Objects (12)

Fibrosis in age-related neovascular macular degeneration in the anti-VEGF era

Fibrosis in age-related neovascular macular degeneration in the anti-VEGF era

Hyperreflective material evolution patterns during long term anti-VEGF therapy in neovascular age-related macular degeneration

Hyperreflective material evolution patterns during long term anti-VEGF therapy in neovascular age-related macular degeneration

Refractory neovascular age-related macular degeneration: time-dependent changes of central retinal thickness with anti-VEGF treatment

Refractory neovascular age-related macular degeneration: time-dependent changes of central retinal thickness with anti-VEGF treatment

The effect of vitreomacular interface in neovascular age-related macular degeneration treated with intravitreal injection of anti-VEGF

The effect of vitreomacular interface in neovascular age-related macular degeneration treated with intravitreal injection of anti-VEGF

Reasons for Delayed Anti-VEGF Treatment During COVID-19 Lockdown and Clinical Impact in Neovascular Age-Related Macular Degeneration

Reasons for Delayed Anti-VEGF Treatment During COVID-19 Lockdown and Clinical Impact in Neovascular Age-Related Macular Degeneration

Fluid dynamics between injections in incomplete anti-VEGF responders within neovascular age-related macular degeneration: a prospective observational study

Fluid dynamics between injections in incomplete anti-VEGF responders within neovascular age-related macular degeneration: a prospective observational study

A Systematic Review of the Treat and Extend Treatment Regimen with Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration

A Systematic Review of the Treat and Extend Treatment Regimen with Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration

Atrophy of retinal vessels in neovascular age-related macular degeneration following long-term treatment with 20 intravitreal anti-VEGF injections

Atrophy of retinal vessels in neovascular age-related macular degeneration following long-term treatment with 20 intravitreal anti-VEGF injections

Long term results of patients with neovascular age-related macular degeneration switched from other anti-VEGF agents to intravitreal Aflibercept

Long term results of patients with neovascular age-related macular degeneration switched from other anti-VEGF agents to intravitreal Aflibercept

Prediction of the short-term efficacy of anti-VEGF therapy for neovascular age-related macular degeneration using optical coherence tomography angiography

Prediction of the short-term efficacy of anti-VEGF therapy for neovascular age-related macular degeneration using optical coherence tomography angiography

Long-term outcomes of intravitreal anti-VEGF therapies in patients affected by neovascular age-related macular degeneration: a real-life study

Long-term outcomes of intravitreal anti-VEGF therapies in patients affected by neovascular age-related macular degeneration: a real-life study

Development of Macular Atrophy in Patients with Wet Age-Related Macular Degeneration Receiving Anti-VEGF Treatment

Development of Macular Atrophy in Patients with Wet Age-Related Macular Degeneration Receiving Anti-VEGF Treatment

Related objects